Zhongda Hospital

This study looked at over 2,600 people with advanced liver cancer that had invaded major blood vessels. Researchers compared standard immunotherapy plus anti-angiogenesis drugs with and without a procedure called TACE (which delivers chemo directly to the liver). The goal was to …

This study tested a combination of three treatments for people with intermediate-stage liver cancer: a procedure that blocks blood flow to the tumor (TACE), drugs that help the immune system fight cancer (PD-1/PD-L1 inhibitors), and drugs that stop blood vessel growth (VEGF-TKI o…

This study tested a combination of three treatments—TACE (a procedure that blocks blood flow to the tumor), immunotherapy (drugs that help the immune system fight cancer), and targeted therapy (drugs that attack cancer cells directly)—in 1244 people with advanced liver cancer tha…

This study tested whether adding a liver-directed chemotherapy infusion (HAIC) to standard drug therapy (immunotherapy plus anti-angiogenesis drugs) improves survival in people with advanced liver cancer that has spread into the main blood vessel of the liver. Over 1,600 particip…

This study tested a combination of three treatments—chemotherapy directly into the liver (HAIC), a targeted drug (donafenib), and an immunotherapy (sintilimab)—in 25 people with bile duct cancer that could not be removed by surgery. The goal was to see if the combination could sh…